Target intelligence / Profile preview

Human cytomegalovirus virion antigen (HCMV antigen)

Target
HCMV antigen
Molecular classification
Other (viral structural proteins), Includes glycoproteins (e.g., gB, gM/gN), capsid proteins, tegument proteins
01

Overview

The human cytomegalovirus virion is a large enveloped DNA virus belonging to the Herpesviridae family. Its structure consists of an inner capsid containing double-stranded DNA surrounded by a protein-rich tegument layer and an outer lipid envelope studded with numerous viral glycoproteins. These antigenic components, collectively referred to as "cytomegalovirus antigens," include major targets like glycoprotein B (gB), which mediates membrane fusion during cell entry; other important envelope complexes such as gM/gN; several capsid proteins responsible for genome packaging; and various tegument proteins involved in assembly and modulation of host responses. The diversity among these molecules means that “cytomegalovirus virion/antigen” does not refer to one unique entity but rather encompasses all immunogenic structures present on the intact virus particle. This term "Cytomegalovirus virion/antigen" is not a specific molecular target but rather refers to the entire set of antigens present on or within the human cytomegalovirus (HCMV) virion. This includes multiple viral proteins from different structural regions (capsid, tegument, envelope), not a single defined molecule. For structured data, it is preferable to specify individual antigens such as "Glycoprotein B" or "Major capsid protein". These antigens elicit both humoral and cellular immune responses during natural infection or vaccination attempts. They play critical roles in pathogenesis—enabling cell entry, evading immunity—and serve as key biomarkers for diagnosis while being targets under investigation for vaccines or antibody-based therapies against HCMV infections.

Other names
Human cytomegalovirus antigenHCMV antigenCMV virion protein(s)Cytomegalovirus structural protein(s)
02

Mechanism of action

Antiviral drugs inhibit DNA polymerase activity after phosphorylation by viral kinases. Monoclonal antibodies neutralize virus by binding to surface glycoproteins such as gB or gM/gN complexes, blocking attachment/fusion with host cells or marking for immune clearance.

03

Biological functions

Viral entry and fusion with host cellsElicitation of immune response / immunogenicityStructural integrity and assembly of virus particleFacilitation of viral replication cycle in host cells
04

Disease associations

Infection (specifically human cytomegalovirus infection)Associated with congenital disease, immunocompromised patient complications
05

Safety considerations

Vaccine development challenges due to complex structure and immune evasion strategies.Potential cross-reactivity with host tissues if using whole-virus preparations.
06

Interacting drugs

Ganciclovir

1 more in the full profile.

07

Biomarkers

Detection of anti-CMV IgG/IgM antibodies in serum indicates exposure/infection.Detection of specific CMV antigens (e.g., pp65) in blood can be used for monitoring active infection.

Beyond the preview

Go deeper on Human cytomegalovirus virion antigen (HCMV antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human cytomegalovirus virion antigen (HCMV antigen).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call